S everal of us struggle with weight and body image issues. Weight loss journey is where one also tries to find the solution ...
The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.
Investor's Business Daily on MSN18h
Eli Lilly Earnings Top, 2025 Guidance Strong, But Weight-Loss Drug Sales MissEli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback